ELUTIA INC (ELUT)
(Delayed Data from NSDQ)
$4.03 USD
+0.02 (0.50%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $3.99 -0.04 (-0.99%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth F Momentum F VGM
Price, Consensus and EPS Surprise
ELUT 4.03 +0.02(0.50%)
Will ELUT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ELUT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ELUT
Are Medical Stocks Lagging DiaMedica Therapeutics (DMAC) This Year?
Beat the Market Like Zacks: Karooooo, UnitedHealth, Amgen in Focus
ELUT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks.com featured highlights BRC, Costamare and Elutia
3 Best Breakout Stocks Worth a Buy for Attractive Returns
Elutia Inc. (ELUT) Upgraded to Buy: Here's Why
Other News for ELUT
Elutia Inc. 2024 Q2 - Results - Earnings Call Presentation
Elutia Inc. (ELUT) Q2 2024 Earnings Call Transcript
Analysts Have Conflicting Sentiments on These Healthcare Companies: Revolution Medicines (RVMD), Fortrea Holdings Inc. (FTRE) and Aziyo Biologics (ELUT)
Elutia price target lowered by $1 at Cantor Fitzgerald, here's why
Elutia Announces Second Quarter 2024 Results